Welcome to Medidata’s resource for news media and others who want to learn more.

Clinical Minds Knowledge Base is starting with a focus on Decentralized Clinical Trials (DCTs). These remote technology solutions helped to propel clinical trials during the COVID-19 pandemic, while patients faced quarantines and lock downs. DCTs have surged in use over the past few years and have been ensuring patients, medical staff, and pharmaceutical, vaccine, and medical device innovators can engage in more meaningful and productive ways.

Please see the resources below for information and subscribe to receive the latest news by visiting the Medidata Newsroom. 

In recent years, decentralization of clinical trial activities has emerged as one of the fastest growing and most essential trends in clinical research. The decentralized clinical trial (DCT) market is projected to reach $16.29 billion in value by 2027.

The pandemic emphasized the crucial role clinical trial technology must play in helping trial operators facilitate studies off-site, as sponsors and contract research organizations (CROs) pivoted towards solutions that would help them conduct and administer remote clinical trials. 

The resources below offer information and insights into how the life sciences industry is leveraging decentralized clinical trials to help maintain and accelerate the development of new therapeutics, vaccines, and medical devices to benefit patients worldwide. See our glossary for key terms, DCT Trends and Stats for key industry data points, and a compelling case study to learn about one of the largest and first decentralized trials.